Inventor · disambiguated record
Thomas Eißing
Also filed as: EISSING THOMAS · EIΒING THOMAS
1 granted patent·4 pending applications·0 citations·filing 2013–2024
14Inventor score
Top patents by PatentIndex Score
5 records- 0157US2025025531A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0255US2024024420A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0353US2023295266A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0452US2023302085A1Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye DisordersREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0543US10285958B2Genotype- or phenotype-based drug formulationBAYER AG·Filed 2013·Granted May 14, 2019·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Eißing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →